Search Results

You are looking at 1 - 6 of 6 items for :

  • "Peritoneal mesothelioma" x
  • Refine by Access: All x
Clear All
Full access

Keli Turner, Sheelu Varghese, and H. Richard Alexander

Diffuse malignant peritoneal mesothelioma (DMPM) is a rare cancer that is ultimately fatal in all afflicted individuals. DMPM represents only 15% to 20% of all mesothelioma diagnoses, with most being the pleural variant. Approximately 400 new

Full access

Tilmann Bochtler, Volker Endris, Anna Reiling, Jonas Leichsenring, Michal R. Schweiger, Sebastian Klein, Fabian Stögbauer, Benjamin Goeppert, Peter Schirmacher, Alwin Krämer, and Albrecht Stenzinger

manifestation of pleural and peritoneal mesothelioma in our patient has also been reported previously, although most patients display mesothelioma only of either pleura or peritoneum. 10 Overall, the frequency of BAP1 mutations in mesotheliomas appears to be

Full access

follows the recent publication of new NCCN Guidelines for Malignant Peritoneal Mesothelioma , bringing the total number of clinical guidelines to 83. “We know there’s a real need to share evidence-based expert recommendations for some of these rarer

Full access

Cancer Summary of changes in the 1.2012 version of the NCCN Guidelines for Colon Cancer from the 3.2011 version include: Clinical Presentation Footnote “a” was modified and the following sentence added: “Peritoneal mesothelioma and other

Full access

Marjorie G. Zauderer and Lee M. Krug

minor responses, and 2 experienced complete resolution of abdominal ascites: 1 from ovarian cancer and 1 from peritoneal mesothelioma. A phase I trial combining SS1P with pemetrexed and cisplatin showed the combination to be safe, with 5 of 7 patients

Full access

Al B. Benson III, J. Pablo Arnoletti, Tanios Bekaii-Saab, Emily Chan, Yi-Jen Chen, Michael A. Choti, Harry S. Cooper, Raza A. Dilawari, Paul F. Engstrom, Peter C. Enzinger, James W. Fleshman Jr., Charles S. Fuchs, Jean L. Grem, James A. Knol, Lucille A. Leong, Edward Lin, Kilian Salerno May, Mary F. Mulcahy, Kate Murphy, Eric Rohren, David P. Ryan, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, William Small Jr., Constantinos T. Sofocleous, Alan P. Venook, and Christopher Willett

chemotherapy according to these NCCN Guidelines. Peritoneal mesothelioma and other extrapleural mesotheliomas may be treated with systemic therapy according to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Malignant Pleural